California State Teachers Retirement System Purchases 54,099,977 Shares of Waters Corporation $WAT

by · The Markets Daily

California State Teachers Retirement System grew its position in Waters Corporation (NYSE:WATFree Report) by 35,116.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 54,254,036 shares of the medical instruments supplier’s stock after purchasing an additional 54,099,977 shares during the period. California State Teachers Retirement System owned about 0.55% of Waters worth $20,347,434,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Pilgrim Global Advisors LLC bought a new stake in Waters in the 2nd quarter worth about $466,131,171,000. BlackRock Inc. bought a new position in shares of Waters during the 2nd quarter worth approximately $3,182,191,000. Jupiter Topco LLC purchased a new position in shares of Waters in the 2nd quarter worth approximately $623,921,000. Norges Bank purchased a new position in shares of Waters in the 4th quarter worth approximately $265,751,000. Finally, Veritas Asset Management LLP grew its holdings in shares of Waters by 112.3% in the fourth quarter. Veritas Asset Management LLP now owns 1,241,206 shares of the medical instruments supplier’s stock valued at $471,447,000 after acquiring an additional 656,436 shares in the last quarter. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Waters

In related news, Director Christopher Kuebler sold 3,626 shares of the business’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the completion of the transaction, the director directly owned 17,808 shares in the company, valued at $7,086,515.52. The trade was a 16.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.31% of the company’s stock.

Waters Price Performance

Shares of NYSE:WAT opened at $409.39 on Tuesday. The company has a 50-day moving average price of $392.72 and a two-hundred day moving average price of $352.26. Waters Corporation has a twelve month low of $282.77 and a twelve month high of $426.22. The company has a quick ratio of 1.29, a current ratio of 1.86 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $40.22 billion, a PE ratio of 102.09, a P/E/G ratio of 2.38 and a beta of 1.19.

Waters (NYSE:WATGet Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, topping analysts’ consensus estimates of $3.01 by $0.04. The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.62 billion. Waters had a return on equity of 11.27% and a net margin of 3.58%.The business’s revenue for the quarter was up 113.3% on a year-over-year basis. During the same period last year, the company earned $2.95 earnings per share. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Equities analysts forecast that Waters Corporation will post 14.56 EPS for the current year.

Analyst Ratings Changes

A number of analysts recently commented on WAT shares. Wall Street Zen downgraded Waters from a “buy” rating to a “hold” rating in a research report on Sunday. Weiss Ratings downgraded Waters from a “hold (c)” rating to a “hold (c-)” rating in a research note on Wednesday, August 12th. Royal Bank Of Canada raised their target price on Waters from $435.00 to $475.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Citigroup boosted their price target on shares of Waters from $425.00 to $470.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, HSBC increased their price target on shares of Waters from $415.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, June 3rd. Three investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $424.35.

Check Out Our Latest Report on Waters

Waters Company Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

See Also

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WATFree Report).